Literature DB >> 6778890

Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO.

R A Lobo, L Granger, U Goebelsmann, D R Mishell.   

Abstract

Twenty-three women considered to have polycystic ovarian disease (PCO) were studied in an effort to better understand the mechanism of inappropriate secretion (IGS) which is so characteristic of these women. Criteria for PCO included oligomenorrhea, infertility, an obesity index (ponderal index, PI) < 12, and an LH:FSH ratio > 3. The mean +/- SE weight and PI for this group were 175 +/- 7.5 lbs. and 11.2 +/- 0.2 respectively. Weight was not correlated with steroid levels in PCO or control women. The mean (+/- SE) of serum androgen concentrations (DHEA-S: 2.9 +/- 0.5 micrograms/ml; androstenedione: 2.6 +/- 0.3 ng/ml; and testosterone: 47 +/- 5 ng%) were all significantly higher than those in control women (p < .05). Total serum estradiol (E2) was comparable to those of controls in the follicular phase, while estrone (E1): E2 ratios averaged 2:1. Serum sex hormone binding globulin-binding capacity (SHBG-BC) averaged 56.8 +/- 4.2 nM which was significantly lower than that of controls (p < .05). The percent unbound E2 was significantly elevated in PCO (62% vs 37%). The mass of unbound E2 was also significantly higher in PCO women (40 +/- 3 pg/ml) than in controls (17 +/- 2 pg/ml) (p < .005). Serum LH:FSH ratios had a positive correlation with the relative and absolute concentration of unbound E2. In control women, unbound E2 correlated significantly with LH levels. This suggests that IGS characteristically found in PCO patients and exemplified by elevated LH;FSH ratios, is the result of the feedback response to elevated levels of unbound (i.e., biologically active) E2.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6778890     DOI: 10.1210/jcem-52-1-156

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

1.  Alpha-fetoprotein, the major fetal serum protein, is not essential for embryonic development but is required for female fertility.

Authors:  Philippe Gabant; Lesley Forrester; Jennifer Nichols; Thierry Van Reeth; Christelle De Mees; Bernard Pajack; Alistair Watt; Johan Smitz; Henri Alexandre; Claude Szpirer; Josiane Szpirer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-24       Impact factor: 11.205

2.  Prolactin pulsatility in polycystic ovarian disease.

Authors:  T Laatikainen; A Tulenheimo
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

Review 3.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 4.  Obesity and PCOS: implications for diagnosis and treatment.

Authors:  Richard S Legro
Journal:  Semin Reprod Med       Date:  2012-10-16       Impact factor: 1.303

Review 5.  Insights into hypothalamic-pituitary dysfunction in polycystic ovary syndrome.

Authors:  J E Hall; A E Taylor; F J Hayes; W F Crowley
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

6.  Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C.

Authors:  W Urdl
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

7.  Serum lipids and memory in a population based cohort of middle age women.

Authors:  V W Henderson; J R Guthrie; L Dennerstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 8.  The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms.

Authors:  R Dumitrescu; C Mehedintu; I Briceag; V L Purcarea; D Hudita
Journal:  J Med Life       Date:  2015 Apr-Jun

9.  Stress promotes development of ovarian cysts in rats: the possible role of sympathetic nerve activation.

Authors:  A Paredes; A Gálvez; V Leyton; G Aravena; J L Fiedler; D Bustamante; H E Lara
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

Review 10.  Psychobiological risk factors for suicidal thoughts and behaviors in adolescence: a consideration of the role of puberty.

Authors:  Tiffany C Ho; Anthony J Gifuni; Ian H Gotlib
Journal:  Mol Psychiatry       Date:  2021-06-11       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.